Crossmark

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

Crossref DOI link: https://doi.org/10.1186/s13075-019-1881-3

Published Online: 2019-04-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Higuchi, Tomoaki

Takagi, Kae

Tochimoto, Akiko

Ichimura, Yuki

Norose, Takanari

Katsumata, Yasuhiro

Masuda, Ikuko

Yamanaka, Hisashi

Morohoshi, Toshiro

Kawaguchi, Yasushi
License Information

Text and Data Mining valid from 2019-04-18
More Information

Article History

Received: 5 October 2018

Accepted: 26 March 2019

First Online: 18 April 2019

Ethics approval and consent to participate

: All subjects enrolled provided written informed consent for the analyses performed. The study was conducted according to the Declaration of Helsinki and approved by the ethics committee of Tokyo Women’s Medical University.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.